Lenz Therapeutics Inc (LENZ) Stock Price, Quote & News

Company Profile

LENZ Therapeutics, Inc. operates as a biopharmaceutical company that focuses on the development and commercialization of therapies to improve vision in the United States. Its product candidates include LNZ100 and LNZ101 which are in Phase III clinical trials for the treatment of presbyopia. LENZ Therapeutics, Inc. was formerly known as Presbyopia Therapies, Inc. and changed its name to LENZ Therapeutics, Inc. in June 2021. The company was founded in 2013 and is headquartered in Solana Beach, Cal...

Industry: Biotechnology

Sector: Healthcare

Phone: 858 925 7000

Website: www.lenz-tx.com

Address:

201 Lomas Santa Fe Drive, Suite 300, Solana Beach, United States

RickR3 Sep. 7 at 3:17 PM

$LENZ Everyone! Lenz Therapeutics Inc. (market cap: $1.19 billion) reached a significant milestone when the stock hit a 52-week high of $41.71. This is the stock that will make us $$$! GLTA!! SOURCE: Lenz Therapeutics stock hits 52-week high at 41.71 USD By Investing.com https://share.google/pPlcluc4WKgb1d3I2

1 · Reply

RickR3 Sep. 7 at 11:15 AM

$LENZ Don't be left behind. If you are still on the fence about $LENZ, now is the time to jump in feet first! Why? I wear glasses, and I'm over 50, but since I'm nearsighted I'm not eligible for VIZZ. However, if I was farsighted and eligible, I would at least try VIZZ to see how well it works since it provides freedom from wearing glasses. Freedom is important since VIZZ will allow older individuals freedom to look at their cell phones, laptops, books, and magazines without having to pop on a pair of glasses or use a magnifying glass. By having an option to not wear glasses is by itself a worthwhile change that people will want to experience firsthand. If they like the experience, VIZZ can catch on very quickly since no strong competition exists. GLTA!!

0 · Reply

RickR3 Sep. 7 at 8:09 AM

$LENZ Did you know that the all-time high LENZ Therapeutics stock closing price was $205.16 on June 30, 2021? Are we going to repeat or exceed the all-time high? It is still too early to tell, but we have a good chance. So far, things are looking good, and if you believe like I believe, we are on the fast track to making some $$$. GLTA!! SOURCE: LENZ Therapeutics - 4 Year Stock Price History | LENZ | MacroTrends https://share.google/7PlSgbjrK4VifadTr

1 · Reply

Paddy444 Sep. 6 at 3:22 PM

$LENZ If you do not wear socks, its ok. However, you might want to use your personal diligent skills this weekend on the substance here. Really learn about the global market share, the immediate gifts of that very thing. Then dabble into the realm of the product the big dogs like, that's why its approved, no shit sherlock. Or don't, who gives a fk in the end, as long as your results are always there without hurting others, well that's a nice warm flame off a solid log. 444 Damn I feel good working right, you? see ya

0 · Reply

MoneyGroupLLC Sep. 6 at 12:52 PM

$LENZ – LENZ Therapeutics awaits FDA decision on its aceclidine eye drop by Aug 8; it has $209.6M in cash and >$195M in licensing payments, with an 88‑member sales force ready for launch; Q2 net loss was $14.9M.

0 · Reply

RickR3 Sep. 6 at 11:13 AM

$LENZ Everyone! LENZ is not a stock that you come across very often. LENZ has recent FDA approval, money, several partnerships, 100+ sales team, quick-to-market strategy, and product affordability. These are the things that you hope for in a company, but for all of us, it is our reality that I believe will jump start LENZ to success! GLTA!! SOURCE: LENZ_Corporate_Presentation_August_2025_Post_Approval_Final - for website .pdf https://share.google/WTQ5MPjavfZfsQp72

1 · Reply

InvestorWisdom Sep. 5 at 3:57 PM

$LENZ gonna try to breakout soon imo. Charts are primed

0 · Reply

FeatherWeight Sep. 5 at 3:32 PM

$LENZ key breakout $31.70 level looks highly likely to be taken out today 🧐 I know too many people who could use and would prefer to their product over continued use of glasses and contact lenses.

1 · Reply

Paddy444 Sep. 4 at 8:00 PM

$LENZ I don't need these drops to see that silky salad on Barry Gibb during Staying Alive but either did the institutions and insiders grasping these shares like each fingertip on a rotary phone 4 digits in Stay cool be kind, work right

0 · Reply

Paddy444 Sep. 4 at 7:48 PM

$LENZ The dance off I just had in the kitchen with myself to Staying Alive, Bee Gees, would drive any tight assed person crazy. Thats cool Bonfire leader is hard up on this, I find that solid Ok, time to pass out standing up, later

0 · Reply

LENZ Therapeutics, Inc. (LENZ) Therapeutics, Inc. Presents At Citi's Biopharma Back To School Conference Transcript

Aug 25, 2025, 8:00 AM EDT - 13 days ago

LENZ Therapeutics to Present at Upcoming Investor and Medical Conferences

Jul 31, 2025, 4:05 PM EDT - 5 weeks ago

LENZ Therapeutics Announces US FDA Approval of VIZZ™ for the Treatment of Presbyopia

Jul 30, 2025, 8:00 AM EDT - 5 weeks ago

LENZ Therapeutics Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights

Jul 29, 2025, 1:32 PM EDT - 5 weeks ago

LENZ Therapeutics: Undervalued Ahead Of PDUFA

Jul 28, 2025, 8:00 AM EDT - 5 weeks ago

LENZ Therapeutics Announces NMPA Submission of New Drug Application for LNZ100 in China for the Treatment of Presbyopia

Jul 7, 2025, 8:00 AM EDT - 2 months ago

LENZ Therapeutics and Laboratoires Théa Announce Exclusive License and Commercialization Agreement for LNZ100 in Canada

Jul 1, 2025, 4:23 PM EDT - 2 months ago

LENZ Therapeutics: Presbyopia Eyedrops Look Promising

May 27, 2025, 8:00 AM EDT - 3 months ago

LENZ Therapeutics to Present at Upcoming Investor Conferences

May 9, 2025, 10:33 AM EDT - 4 months ago

LENZ Therapeutics, Inc. (LENZ) Q1 2025 Earnings Call Transcript

May 9, 2025, 9:03 AM EDT - 4 months ago

LENZ Therapeutics and Lotus Pharmaceutical Announce Exclusive License and Commercialization Agreement for LNZ100 in the Republic of Korea and Southeast Asia

May 7, 2025, 4:05 PM EDT - 4 months ago

LENZ Therapeutics Reports First Quarter 2025 Financial Results and Recent Corporate Highlights

May 6, 2025, 4:30 PM EDT - 4 months ago

LENZ Therapeutics to Participate in Upcoming BofA Securities 2025 Health Care Conference

Apr 30, 2025, 4:30 PM EDT - 4 months ago

LENZ Therapeutics to Report First Quarter 2025 Financial Results and Recent Corporate Highlights on May 7th, 2025

Apr 7, 2025, 8:00 AM EDT - 5 months ago

LENZ Therapeutics: Freedom From Reading Glasses

Mar 27, 2025, 5:33 PM EDT - 5 months ago

LENZ Therapeutics Stock Is Attractive Before PDUFA

Mar 19, 2025, 8:09 PM EDT - 6 months ago

LENZ Therapeutics, Inc. (LENZ) Q4 2024 Earnings Call Transcript

Mar 19, 2025, 4:05 PM EDT - 6 months ago

LENZ Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Highlights

Mar 11, 2025, 8:00 AM EDT - 6 months ago

LENZ Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Highlights on March 19, 2025

Mar 3, 2025, 8:00 AM EST - 6 months ago

LENZ Therapeutics to Host Commercial Day on April 15, 2025

Feb 24, 2025, 8:00 AM EST - 6 months ago

LENZ Therapeutics to Participate in Upcoming Investor Conferences

Nov 6, 2024, 11:43 AM EST - 10 months ago

LENZ Therapeutics, Inc. (LENZ) Q3 2024 Earnings Call Transcript

Oct 28, 2024, 1:51 PM EDT - 11 months ago

LENZ Therapeutics' Investigational Drug For Age-Related Blindness Aces Pivotal China Trial, Analyst Says Data Readout May Strengthen Position For Ex-U.S. Partnerships

Oct 27, 2024, 9:00 PM EDT - 11 months ago

CORXEL and LENZ Therapeutics Announce Positive Topline Data from China Phase 3 Presbyopia Trial of LNZ100

Oct 21, 2024, 8:00 AM EDT - 11 months ago

LENZ Therapeutics Announces FDA Acceptance of New Drug Application for LNZ100 for the Treatment of Presbyopia

Oct 15, 2024, 8:00 AM EDT - 11 months ago

Lucy Therapeutics Appoints Kim Drapkin as Board Chair

ABOS

Aug 30, 2024, 8:00 AM EDT - 1 year ago

LENZ Therapeutics: Upcoming PDUFA, Strong Data, Some Risks

Aug 16, 2024, 7:43 PM EDT - 1 year ago

LENZ Therapeutics, Inc. (LENZ) Q2 2024 Earnings Call Transcript

Aug 14, 2024, 4:05 PM EDT - 1 year ago

LENZ Therapeutics Reports Second Quarter 2024 Financial Results

Aug 12, 2024, 8:00 AM EDT - 1 year ago

LENZ Therapeutics Announces Submission of New Drug Application to U.S. Food and Drug Administration for LNZ100 for the Treatment of Presbyopia

Aug 7, 2024, 4:01 PM EDT - 1 year ago

LENZ Therapeutics to Report Second Quarter 2024 Financial Results on August 14, 2024

Jun 10, 2024, 8:00 AM EDT - 1 year ago

LENZ Therapeutics to Host Key Opinion Leader Event on June 18, 2024

May 30, 2024, 8:00 AM EDT - 1 year ago

LENZ Therapeutics to Present at the Jefferies Global Healthcare Conference

May 11, 2024, 7:26 AM EDT - 1 year ago

LENZ Therapeutics, Inc. (LENZ) Q1 2024 Earnings Call Transcript

May 8, 2024, 4:01 PM EDT - 1 year ago

LENZ Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates

May 1, 2024, 4:01 PM EDT - 1 year ago

LENZ Therapeutics to Report First Quarter Financial Results and Business Update on May 8, 2024

Apr 3, 2024, 7:49 AM EDT - 1 year ago

Lenz Therapeutics' eye disease drugs meet main goal of late-stage study

Apr 3, 2024, 7:00 AM EDT - 1 year ago

LENZ Therapeutics Announces Positive Topline Data from Phase 3 CLARITY Presbyopia Trials

Apr 2, 2024, 4:01 PM EDT - 1 year ago

LENZ Therapeutics to Host Investor Call to Discuss Topline Results from the Phase 3 CLARITY Presbyopia Trials

Mar 21, 2024, 4:30 PM EDT - 1 year ago

LENZ Therapeutics Announces Completion of Merger with Graphite Bio and Provides Update on Recent Clinical and Corporate Progress

RickR3 Sep. 7 at 3:17 PM

1 · Reply

RickR3 Sep. 7 at 11:15 AM

0 · Reply

RickR3 Sep. 7 at 8:09 AM

1 · Reply

Paddy444 Sep. 6 at 3:22 PM

0 · Reply

MoneyGroupLLC Sep. 6 at 12:52 PM

0 · Reply

RickR3 Sep. 6 at 11:13 AM

1 · Reply

InvestorWisdom Sep. 5 at 3:57 PM

$LENZ gonna try to breakout soon imo. Charts are primed

0 · Reply

FeatherWeight Sep. 5 at 3:32 PM

$LENZ key breakout $31.70 level looks highly likely to be taken out today 🧐 I know too many people who could use and would prefer to their product over continued use of glasses and contact lenses.

1 · Reply

Paddy444 Sep. 4 at 8:00 PM

0 · Reply

Paddy444 Sep. 4 at 7:48 PM

0 · Reply

Toowired2 Sep. 4 at 6:26 PM

I am really liking $LENZ after reading about their new vizz eye drops. Did you know 1.8 billion people in the world and 148 million people in the United States suffer from Presbyopia. This is a God send for most of us over 50. Vuity is another drug on the market that's been out but the side effects are almost worse than the fix. The major side affect is it makes you long range vision worse. If I wanted that worse I could just swap glasses. This eye drop really does sound amazing --LENZ Therapeutics recently received FDA approval for its Vizz eye drops to treat presbyopia in adults, offering a new non-surgical solution for age-related farsightedness

2 · Reply

Rmccall Sep. 4 at 4:58 PM

$LENZ totally agree with @Paddy444!!! Still have no clue what he's talking about but it seems very positive!!! lol

1 · Reply

Paddy444 Sep. 4 at 4:05 PM

$LENZ This is hilarious to me.. I have seen this show so many times with 3 D glasses, well that's what it felt like when low volume on intentional hidden substance is about to get released. A true beaut wagon this is right now. 3D time aka heavy 3 day volume is going to be so damn funny and soon to. Classic Stay cool

0 · Reply

Rmccall Sep. 4 at 5:04 AM

$LENZ yeah I messed that post up. Need the VIZZ!!!! lol

0 · Reply

Rmccall Sep. 3 at 11:44 PM

$LENZ Be patient!!! Good things take time!! We all can see what visualize what going to happen here!!! Get that!!!

0 · Reply

Zkillerz323 Sep. 3 at 6:00 PM

$LENZ waiting waiting waiting

1 · Reply

Rmccall Sep. 3 at 5:37 PM

$LENZ long term diamond!!!

0 · Reply

RickR3 Sep. 3 at 2:59 PM

$LENZ Remember, we are in it to WIN IT! $LENZ is a winner and great things are coming our way! Invest with confidence because each day brings us closer to achieving our goals. GLTA!!

0 · Reply

RickR3 Sep. 3 at 2:13 PM

$LENZ Everyone! Let's not forget LENZ agreement with Thea to register and commercialize LNZ100 for the treatment of presbyopia in Canada. Under the terms of the licensing and commercialization agreement, LENZ will be eligible to receive over $70 million in upfront, regulatory and commercial milestone payments, as well as tiered, double-digit royalties on net sales. Combined with the other overseas partnerships, it is only a matter of time before things really start moving. Now, is the best time to consider your current position. $LENZ is going to improve lives and make a lot of $$$. GLTA!! SOURCE: https://finance.yahoo.com/news/lenz-therapeutics-laboratoires-th-announce-120000711.html

0 · Reply

Paddy444 Sep. 3 at 11:05 AM

$LENZ ,overseas partnerships, approved, only option, masses will be interested in all manners, not next year, this month, conferences, media, meetings, really it's just now. Lotus- exclusive- No? its ok, will never change my results. Just results, just Paddy, never hurting or using others Work right 444 Nectar unfortunately coming out for a morning bonfire and good times All cool

0 · Reply

RickR3 Sep. 1 at 12:58 PM

$LENZ If you don't know, LENZ is already moving at full steam ahead since one of it partners has recently applied for a New Drug Application for LNZ100 in China. This completes the first milestone under their partnership licensing agreement. "Under the terms of the License, LENZ is eligible to receive up to $95.0 million of regulatory and sales milestones, as well as tiered mid single-digit to low double-digit royalties on net sales in Greater China." LENZ's overseas partnerships will strengthen LENZ financial position and hopefully, enable the company for continued success. GLTA!! SOURCE: LENZ Therapeutics Announces NMPA Submission of New Drug Application for LNZ100 in China for the Treatment of Presbyopia :: LENZ Therapeutics, Inc. (LENZ) https://share.google/8fGnmxAivOKEwpaQ1

0 · Reply

RickR3 Sep. 1 at 12:02 AM

$LENZ The word is getting out about $LENZ. In early September, the company has an aggressive schedule with back-to-back conferences. The company is laser focused, and this is only the beginning. LENZ is coming out of the starting gate with a loud bang! I highly believe that this time next year the current SP will be only a memory. Hopefully, you get in before others find out about this Pot of Gold. GLTA!! SOURCE: LENZ Therapeutics to Present at Upcoming Investor and Medical Conferences. https://finance.yahoo.com/news/lenz-therapeutics-present-upcoming-investor-120000090.html

0 · Reply

Market Cap	1.20B
Revenue (ttm)	0.00
Net Income (ttm)	-49.77M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	511,400
Avg Vol	511,108
Day's Range	N/A - N/A
Shares Out	28.52M
Stochastic %K	98%
Beta	0.45
Analysts	Strong Sell
Price Target	$49.71